Hemostats Changing the Outlook By 2026
Hemostats,
also referred to as hemostatic clamp, arterial forceps or pean are
surgical tools used in surgical procedures to control bleeding. The
hemostats were designed to clamp blood vessels of small size to
manage blood flow in hemorrhagic cases. These devices are also used
to grasp and secure superficial fascia during wound closure surgical
procedures. The hemostats, with hinges and rings, are visibly similar
to scissors. These instruments have a locking mechanism known as
rachet that is used for clamping wherein the jaws of locking forceps
come together, which helps in sealing the opening of the blood
vessels. In many cases, the hemostats can be used to hold the
subcutaneous tissues on the edges of the wound, while the tissue
forceps are applied to the other edge to retract and gain better
exposure to the wound site. Hemostats serve as an excellent tool to
visualize, expose, and investigate deeper tissue areas in case of
patients with serious injuries. The hemostats securely holds blood
vessels and other tubular structures to obstruct the blood or fluid
flow in damaged vessels. It is available in various sizes and
patterns depending on the requirement of the application. The use of
hemostats is expanding gradually, as uncontrolled bleeding in the
surgical trauma settings frequently result into significant clinical
and economic impact that can even lead to loss of life.
Global Hemostats Market Dynamics
Rising volumes of
surgical procedures performed across the world coupled with
increasing number of trauma and accident injury cases is expected to
foster growth of global hemostats market. For instance, according to
the Health and Social Care Information Centre (HSCIC), surgery is one
of the most important treatments offered by NHS care in the U.K., and
accounted for 4.7 million admissions across multiple medical domains
in 2013 -14. The use of these instruments does not require any
specific technical expertise and thus, can be used at even the
smallest clinics creating a massive customer base and market growth
potential. Moreover, the use of these instruments can be found not
only in trauma injury surgical procedures but also in complex
surgeries that involves significant blood loss due to larger
incisions made on the patients’ skin such as open heart surgery,
hernia repair surgery, joint repair surgery, cardiovascular surgery,
and other neurologic surgeries. For instance, according to the
American Joint Replacement Surgery 2016, nearly 427,181 total
surgical procedures were reported for joint replacement surgery in
the U.S. However, the cluttering of surgical field due to multiple
clamp attachment causing inconvenience to the surgeons and thus,
leading to surgical errors is expected to hinder the market growth.
Global Hemostats Market Regional Insights
On the basis of
region, the global hemostats market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America holds the dominant position in the global hemostats market,
owing to large number of surgeries performed in the region as well as
development of technologically advanced products for achieving blood
control during trauma management procedures. According to the
National Health Statistics Report by the Centers of Disease Control &
Prevention, around 201,748.3 million surgical and non-surgical
procedures were performed in the U.S. in 2011. The data also suggests
that 28.6 million visits to ambulatory surgery cases were reported in
the U.S.
Asia Pacific is
expected to gain significant traction in the global hemostats market
in the near future. Marginal market share would be grasped by the
local players entering into the market due to less stringent
regulatory requirements for manufacturing of these instruments and
growing customer pool due to rapid development of healthcare
infrastructure in various economies of Asia Pacific. For instance,
Tonglu BA Medical Devices Co., Ltd and Suzhou Texnet Commerce Co.,
Ltd are China-based hemostat manufacturing companies that offers
similar surgical hemostats to that of the major international players
at significantly lower costs. The increasing entry of new players
into the market is thus, responsible for faster growth of Asia
Pacific region in the global hemostats market.
Global Hemostats Market Competitive Analysis
Key players operating
in the global hemostats market include B.Braun Melsungen AG,
CareFusion Corporation, Pentax Medical, Shanghai Medical Instruments,
Teleflex Medical, Asa Dental, J & J Instruments, and others.
Major players are focusing on incorporation of technological
advancements to establish their significance and retain their
dominance in the market. For instance, in November 2016, Pentax
Medical introduced a HemoStat WideCup, a bipolar hemostatic forceps
that helps in achieving easy control of bleeding during endoscopic
therapy procedures of gastric cancer.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1598
Global Hemostats Market Taxonomy:
On the basis of instrument type:
• Halstead
mosquito hemostatic forceps
• Kelly and
Crile hemostatic forceps
•
Rochester-Carmalt hemostatic forceps
On the basis of end user:
• Hospitals
•
Multi-specialty clinics
• Ambulatory
surgical centers
• Nursing homes
• Others
On the basis of region:
• North America
• Europe
• Asia Pacific
• Latin America
• Africa
• Middle East
About Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market
Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment